Eicosapentaenoic Acid EPA Powder: Specifications and Sourcing

Microencapsulated EPA powder with a technical specification sheet showing assay, oxidation stability, and sourcing criteria
Table of Contents

Eicosapentaenoic acid EPA powder is a dry omega-3 ingredient developed for applications where liquid oil is difficult to weigh, blend, fill, or protect from environmental exposure.

The powder may contain EPA-rich fish or algal oil within a microencapsulation matrix. Products sold under the same name can nevertheless differ substantially in EPA concentration, DHA content, carrier composition, fatty-acid form, oxidation stability, and processing performance.

For B2B buyers, the most useful starting question is:

How many milligrams of stable EPA does each gram of finished powder deliver?

A reliable purchasing decision should be based on powder-basis EPA content, oxidation data, application testing, batch documentation, and total cost in use—not product name or headline purity alone.

EPA Powder Buyer Snapshot

Procurement pointWhat buyers should confirm
EPA assayMilligrams of EPA per gram of finished powder
DHA contentSeparate DHA result and EPA:DHA ratio
SourceFish oil, algal oil, or another declared source
Fatty-acid formTG, rTG, EE, FFA, or another specified form
Carrier systemComplete encapsulation matrix and allergen status
OxidationPeroxide value, p-anisidine value, TOTOX, and sensory condition
DocumentationSpecification, batch COA, TDS, SDS, and available test reports
Commercial termsSample availability, packaging, MOQ, lead time, and repeat supply

What Is Eicosapentaenoic Acid EPA Powder?

Eicosapentaenoic acid, abbreviated as EPA, is a long-chain omega-3 polyunsaturated fatty acid. It is commonly written as 20:5 n-3, referring to a 20-carbon chain with five double bonds.

The PubChem record for eicosapentaenoic acid identifies its molecular formula as C20H30O2. The NIH Omega-3 Fatty Acids Fact Sheet explains that EPA and DHA occur in marine foods and omega-3 supplements, although their concentrations vary widely among sources and formulations.

A commercial EPA powder is normally not pure EPA in dry form. It is a delivery system containing EPA-rich oil within a carrier matrix.

Depending on the grade, the complete ingredient may include:

  • EPA and DHA
  • Other fatty acids
  • Maltodextrin or modified starch
  • Gum, gelatin, or protein carriers
  • Emulsifiers
  • Antioxidants
  • Flow or moisture-control ingredients
  • Permitted processing aids

These components affect more than the ingredient declaration. They influence active loading, allergen status, bulk density, dispersibility, sensory performance, and the amount of powder required per serving.

Buyers evaluating Essencefield’s available EPA powder options should request the current grade-specific specification and representative COA before comparing the material with another supplier.

What Does EPA Percentage Actually Mean?

EPA percentage can refer to the complete powder, the encapsulated oil phase, or the measured fatty-acid fraction. Values reported on different bases cannot be compared directly.

EPA as a percentage of total fatty acids is not equivalent to EPA as a percentage of the finished commercial powder.

Supplier statementPossible meaningWhat the buyer should request
EPA 90%EPA is 90% of the measured fatty-acid fractionEPA in mg/g of complete powder
Oil content 50%Half of the powder consists of encapsulated oilEPA concentration within the oil phase
Total omega-3 30%Combined EPA, DHA, and other omega-3 fatty acidsSeparate EPA and DHA values
EPA powder 10%Often means 100 mg EPA per gram of powderConfirmation that the assay is powder-based
EPA/DHA 18/12May describe the oil or the complete ingredientUnits, test basis, and analytical method

Consider a theoretical powder containing 50% oil. If EPA represents 60% of that oil phase, the finished powder would theoretically contain approximately 30% EPA before accounting for moisture, analytical basis, and manufacturing tolerance.

For formulation and quotation comparison, the most useful result is generally:

EPA in milligrams per gram of finished powder

The specification or COA should also state:

  • Test method
  • Reporting units
  • Minimum or target limit
  • As-is or dry-basis reporting
  • Separate EPA and DHA values
  • Total omega-3 where relevant

“High-purity EPA” is commercially ambiguous unless the supplier defines what the purity percentage measures.

Which Type of EPA Powder Fits the Application?

Microencapsulated fish-oil EPA powder

Microencapsulated fish-oil powder is widely used in dry dietary supplements and nutrition products.

EPA-containing oil is emulsified into a carrier system and converted into powder, commonly through spray drying. The matrix helps transform liquid oil into a material that can be weighed, blended, filled, and transported through conventional dry-processing systems.

Potential advantages include:

  • Easier dry blending
  • Lower leakage risk
  • More uniform distribution in powder formulas
  • Better compatibility with capsules and sachets
  • Reduced direct contact between oil and oxygen
  • Improved control of marine odor and flavor

Microencapsulation does not make EPA immune to oxidation. Oil quality, wall-material composition, droplet size, surface oil, moisture, drying conditions, and packaging all influence stability.

Peer-reviewed research on fish-oil microencapsulation and spray drying shows that process and carrier selection can produce meaningful differences in encapsulation efficiency and oxidation during storage.

Algae-derived EPA powder

Algal EPA powder may suit products requiring a fish-free source or a particular sustainability position.

However, “algae omega-3 powder” should not be assumed to mean EPA-rich powder. Many commercial algal oils contain substantially more DHA than EPA.

Buyers should confirm:

  • Algal species or strain
  • EPA and DHA concentrations
  • Extraction and concentration process
  • Carrier composition
  • Allergen status
  • Vegetarian or vegan suitability
  • Residual solvent controls
  • Regulatory status in the destination market

Projects focused mainly on DHA should be evaluated separately. Essencefield’s DHA Powder page provides a distinct sourcing reference for DHA-oriented formulations.

Specialized high-load EPA forms

Specialized powders may use free fatty acids, salts, molecular complexes, or directly compressible systems to increase active loading or change powder behavior.

These forms require independent evaluation of:

  • Chemical form
  • EPA concentration
  • Compression and flow
  • Release characteristics
  • Oxidation stability
  • Regulatory status
  • Intellectual-property restrictions
  • Cost in use

They should not be treated as direct replacements for conventional microencapsulated EPA powder without formulation trials and regulatory review.

Which EPA Powder Specifications Matter Most?

The strongest purchasing specifications connect every parameter with a practical commercial risk.

ParameterProcurement riskWhat to verify
EPA assayIncorrect dose and cost calculationEPA in mg/g of finished powder
DHA assayIncorrect EPA:DHA positioningSeparate DHA value
Total omega-3EPA may be overstated by combined valuesIndividual fatty-acid results
Fatty-acid formDifferent processing or labeling implicationsTG, rTG, EE, FFA, or another form
Peroxide valuePrimary oxidation may already be presentLimit, method, and tested material
p-Anisidine valueSecondary oxidation may be overlookedLimit and extraction method
TOTOXIncomplete overall oxidation assessmentCalculation basis and applicability
Surface oilOdor, stickiness, and stability riskExtraction and calculation method
MoistureCaking and storage riskTest method and release limit
Water activityMoisture-related stability riskResult where application-relevant
Particle sizeSegregation, dust, and mouthfeelDistribution rather than “fine powder” only
Bulk densityCapsule capacity and pack volumeLoose or tapped density
DispersibilityFloating and sedimentationTest pH, temperature, and mixing conditions
MicrobiologyFinished-product suitabilityMarket-appropriate limits
Heavy metalsCompliance and safety riskLead, arsenic, cadmium, and mercury
Marine contaminantsSource-specific contamination riskDioxins and PCBs where required

EPA, DHA, and fatty-acid profile

A batch COA should report EPA and DHA separately. “Total omega-3” cannot replace these values because it may include fatty acids that do not contribute to the target EPA dose.

Gas chromatography is commonly used to determine fatty-acid composition. The buyer should confirm whether results are reported as:

  • Percentage of total fatty acids
  • Percentage of the oil fraction
  • Percentage of complete powder
  • Milligrams per gram
  • Milligrams per serving

The approved commercial specification should also distinguish between a guaranteed minimum, a target range, and a nonbinding typical value.

Carrier and allergen disclosure

Request the complete carrier composition rather than accepting “microencapsulated powder” as a sufficient description.

The formulation may include:

  • Maltodextrin
  • Modified starch
  • Gum arabic
  • Gelatin
  • Milk protein
  • Soy-derived emulsifiers
  • Antioxidants
  • Flow agents

These materials may affect allergen labeling, vegan positioning, carbohydrate contribution, processing performance, and customer acceptance.

Lower carrier content can improve active loading, but it does not automatically produce better stability. Surface oil, moisture, packaging, and real-time oxidation performance remain important.

Physical performance

A specification stating only “fine powder” provides limited manufacturing value.

Particle size, density, and flow can determine whether the powder:

  • Segregates from other ingredients
  • Flows through a hopper
  • Fits into the intended capsule
  • Compresses consistently
  • Produces excessive dust
  • Creates a gritty mouthfeel
  • Disperses acceptably

A lipid powder described as water dispersible may form an opaque suspension or emulsion. It should not be represented as truly water soluble unless testing supports that claim.

How Should Oxidation and Shelf Life Be Evaluated?

EPA contains multiple double bonds and is vulnerable to oxygen, heat, light, and pro-oxidant metals.

A high release assay does not show whether the ingredient will retain acceptable potency, odor, and flavor throughout storage.

The Codex Alimentarius Standard for Fish Oils gives the following limits for most fish-oil categories covered by the standard:

  • Peroxide value: no more than 5 meq active oxygen/kg oil
  • p-Anisidine value: no more than 20
  • TOTOX: no more than 26

TOTOX is commonly calculated as:

TOTOX = 2 × peroxide value + p-anisidine value

Peroxide value reflects primary oxidation products, while p-anisidine value reflects certain secondary oxidation products. A low peroxide value alone does not always demonstrate that an oil is in good condition.

Codex limits apply to defined fish oils. They should not be copied mechanically into an EPA powder specification without confirming:

  • What material is tested
  • How oil is extracted from the powder
  • Whether the method is validated for the carrier matrix
  • Whether results are reported on an oil or powder basis

Surface oil

Surface oil is located on or near the outside of the powder particle and is generally more exposed to oxygen than oil retained within the matrix.

Elevated surface oil may contribute to:

  • Marine odor
  • Faster oxidation
  • Stickiness
  • Reduced powder flow
  • Oil migration
  • Packaging interaction
  • Sensory deterioration

Comparisons between suppliers are meaningful only when test and extraction methods are equivalent.

Real-time stability

Accelerated studies can identify potential formulation weaknesses, but they do not replace real-time data in representative commercial packaging.

A useful stability report should state:

  • Batch number
  • Packaging configuration
  • Storage temperature and humidity
  • Sampling intervals
  • EPA and DHA results
  • Oxidation indicators
  • Moisture
  • Appearance and odor
  • Acceptance criteria

Open-package stability should also be considered. Repeated exposure during production can introduce oxygen and moisture even when the unopened package has an acceptable shelf life.

Pack size, headspace, resealing procedure, warehouse conditions, and expected time after opening should therefore be included in the handling plan.

Which Applications Are Suitable for EPA Powder?

ApplicationCritical propertiesCommon failure risksQualification test
Hard capsulesAssay, density, and flowExcessive capsule count or variable fillCapsule-filling trial
TabletsFlow, compressibility, and surface oilSticking, capping, or odor releasePilot compression
SachetsFlow and dose uniformityPoor filling or moisture pickupFilling and seal trial
Beverage premixesWetting and dispersibilityFloating, sedimentation, or ringsReconstitution test
Protein powdersBlend and oxidation compatibilitySegregation or flavor driftFinished-formula stability
Nutrition barsOil migration and sensory stabilityRancidity or texture changeProcess and shelf-life trial
Mineral formulasResistance to pro-oxidant metalsAccelerated oxidationFormula-specific testing

Capsules and tablets

Assay and bulk density determine whether the target EPA dose can fit into a practical dosage form.

For a formula targeting 300 mg EPA:

Powder-basis EPA assayTheoretical powder required
10%3,000 mg
20%1,500 mg
30%1,000 mg

These quantities exclude excipients and formulation overage.

Capsule developers should confirm powder flow, bulk density, fill-weight uniformity, and the number of capsules needed per serving.

Tablet developers should evaluate whether compression affects particle integrity, odor release, sticking, hardness, or friability.

Beverage premixes

EPA powder should be tested in the intended beverage system rather than in plain water alone.

Evaluate:

  • Wetting time
  • Floating particles
  • Sedimentation
  • Surface rings
  • Turbidity
  • Odor and flavor
  • Mouthfeel
  • Performance at the intended pH
  • Stability after reconstitution

Acids, proteins, minerals, sweeteners, and mixing energy can change performance. A powder suitable for an opaque protein drink may not be appropriate for a clear acidic beverage.

Protein, mineral, and multi-ingredient formulas

Iron, copper, and other transition metals may accelerate lipid oxidation. Botanical extracts, flavors, and hygroscopic ingredients may also affect moisture movement, sensory quality, and flow.

Finished-product stability should therefore be tested in the complete formula and commercial package rather than inferred solely from the raw-material COA.

EPA Powder vs. Liquid Fish Oil

Evaluation factorEPA powderLiquid fish oil
Dry blendingGenerally easierRequires emulsification or another incorporation method
Tablets and sachetsMore compatibleUsually unsuitable without conversion
Active loadingReduced by carriers in many gradesOften higher
Leakage riskLower in a stable powder systemHigher in unsuitable formats
Sensory controlMay benefit from encapsulationRequires direct odor and flavor management
Oxidation riskInfluenced by surface oil and matrixInfluenced by oil quality and headspace
Cost per kilogramOften higherOften lower
Best fitDry supplements and nutrition systemsSoftgels, liquids, and oil-based products

Neither format is universally better. Powder may justify a higher raw-material price when it enables a viable dosage form, reduces oil-handling problems, or improves compatibility with a dry formulation.

How Should EPA Powder Quotations Be Compared?

Price per kilogram of powder is not a reliable comparison unless the grades have the same EPA concentration and calculation basis.

Use this initial calculation:

Theoretical cost per kilogram of EPA = Powder price per kilogram ÷ EPA concentration as a decimal

Illustrative example:

ItemGrade AGrade B
Powder price$32/kg$70/kg
EPA in finished powder10%30%
Powder required for 1 kg EPA10 kg3.33 kg
Theoretical cost per kg EPA$320Approximately $233

This example is for calculation purposes and does not represent an Essencefield quotation.

A complete cost-in-use analysis should also include:

  • DHA contribution
  • Formulation overage
  • Process loss
  • Capsule or tablet capacity
  • Carrier contribution
  • Flavor-management cost
  • Packaging requirements
  • Production yield
  • MOQ
  • Freight and duties
  • Retesting
  • Stability risk
  • Rejected-lot risk

The lowest powder price may become the most expensive option when it requires more capsules, produces poor sensory performance, or fails finished-product stability testing.

How Essencefield Supports EPA Powder Procurement

Essencefield uses a specification-led sourcing process rather than treating all EPA powders as interchangeable.

Its ingredient sourcing service can support supplier comparison, specification matching, document review, sample evaluation, testing coordination, and bulk supply planning.

Procurement stageTypical support
Requirement reviewTarget EPA, DHA range, source, application, quantity, and market
Grade comparisonAssay basis, carrier, fatty-acid form, and physical properties
Document reviewSpecification, COA, TDS, SDS, allergen, and origin records
Sample qualificationRaw-material sample and application-trial coordination
Testing reviewAssay, microbiology, contaminants, and third-party testing
Commercial confirmationPackaging, MOQ, price, lead time, and delivery terms
Repeat supplyApproved specification, batch documents, and change review

Essencefield’s raw-material quality process covers supplier qualification, specification approval, COA review, incoming inspection, material release, and batch traceability.

Its testing and certification support can coordinate available specifications, batch COAs, technical files, third-party reports, and manufacturing-site certification records.

The exact assay, source, carrier composition, MOQ, packaging, certification scope, and lead time remain grade- and project-specific. They should be confirmed before sample approval or commercial ordering.

Regulatory and Labeling Considerations

Ingredient status, labeling, and permitted EPA claims differ by country and finished-product category.

In the United States, the FDA permits certain qualified health claims involving EPA and DHA only under defined conditions. The required wording reflects that the supporting evidence is inconsistent and inconclusive. The FDA’s EPA and DHA qualified health-claim guidance should be reviewed before developing consumer-facing claim language.

FDA rules also restrict nutrient-content claims such as “high in EPA,” “rich in EPA,” and “excellent source of EPA.”

Before launch, confirm:

  • Ingredient status
  • Intended use
  • Serving level
  • Nutrition or Supplement Facts calculation
  • Fish-allergen labeling
  • Permitted claims
  • Required qualifying language
  • Destination-market documentation

Supplier marketing statements should not be copied directly onto a finished-product label without regulatory review.

An EPA powder ingredient is also not automatically equivalent to a prescription EPA drug or pharmaceutical active ingredient.

Request an EPA Powder Specification, COA, or Sample

A complete inquiry helps identify a technically and commercially appropriate grade.

Provide:

  • Target EPA content
  • Acceptable DHA range
  • Preferred source
  • Required fatty-acid form
  • Intended dosage form
  • EPA target per serving
  • Trial and annual quantity
  • Destination market
  • Carrier or allergen restrictions
  • Required test parameters
  • Packaging preference
  • Required documents
  • Delivery schedule

Use the Essencefield contact form to request an available specification, representative COA, sample, documentation package, and commercial quotation.

The most suitable eicosapentaenoic acid EPA powder is the grade that delivers a clearly defined EPA dose, remains stable in the intended formula and packaging, and is supported by appropriate batch documentation and repeat-supply controls.

Request a Manufacturing Quote

Please use the form below to share your ingredient requirements—product category, target application, desired specifications (e.g., assay/ratio, mesh size, carrier), and estimated order quantity. If you need OEM/private label, include dosage form and key label claims. We’ll route your request to the right team and recommend suitable ingredients, testing/documentation options, packaging, and lead times. You’ll receive indicative pricing, MOQ, and a sample/approval plan.

Picture of Essencefield Editorial Team | Ingredient Science, Quality & OEM Manufacturing

Essencefield Editorial Team | Ingredient Science, Quality & OEM Manufacturing

We publish technical guides for B2B sourcing and formulation of botanical ingredients, including typical COA/Spec ranges, risk-based testing plans, documentation, and OEM/private-label manufacturing. Content is reviewed to align with manufacturing feasibility, batch traceability, and quality control practices used for global export projects.

Reviewed By: Essencefield QA & Technical Team (Quality System)

Documents (on request): COA · TDS/Spec · SDS · Allergen/GMO statements · Regulatory declarations (market-dependent)

More Posts